PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1250710
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1250710
According to Stratistics MRC, the Global Medical Foam Market is accounted for $28.09 billion in 2022 and is expected to reach $48.43 billion by 2028 growing at a CAGR of 9.5% during the forecast period. Medical grade foams are quite different from any other commodity foams in that they are specially formulated for a variety of difficult applications in the medical industry and are rated biocompatible, non-toxic, low particulate, and sterilized. Due to their contaminant resistance and ability to effectively clean rooms for anti-bacterial applications, these medical grade foams prove to be of utmost importance for the medical sector. This lowers the risk of illness and the spread of germs, which is quite common in hospitals.
According to the World Trade Organisation, Medical goods' share in global commerce increased from 5.3% in 2019 to 6.6% in 2020. Global trade in pandemic-fighting goods such as face masks, gloves increased by 31% in 2020. Which is predicted to make a significant contribution to the medical foam market size.
Adoption of medical foam in spinal implants
The market for medical foam is expanding as it becomes more frequently used in spinal implants and of its extensive properties, which include a remarkable strength-to-weight ratio, excellent biocompatibility, superior performance, and cost effectiveness. For instance, Xenco Medical announced the nationwide launch of CancelleX Bio-inspired Spinal Implants in June 2020. These implants are the first titanium foam spine implants that have been injection-molded and pre-attached to disposable instruments. The CancelleX lumbar intrabodies from Xenco Medical are a pioneer in the use of injection molding in the production of titanium spinal implants. Such product introductions are accelerating the growth of the medical foam market, propelling the sector's growth over the forecast period.
Fluctuations of raw material prices
Variations in raw materials are anticipated to be the biggest barrier to the global market for medical foam, according to the report. Crude oil sets the price of benzene, and significant price swings could lead to losses. The cost of polystyrene foam is influenced by the cost of styrene and other raw materials. By affecting the profitability of market competitors, such changes are likely to impede market growth.
Government investments in the healthcare sector
Numerous factors, including the aging population, rising global health expenditures, and the quickening growth of the medical sector, are cited for the expansion of the medical foam market worldwide. Additionally, the growing government investments in the healthcare sector are fueling the expansion of the medical foam industry. Furthermore, the growing global population and consumer focus on health and regular cleanliness are driving up demand for high-quality medical foam that can be used in a variety of applications.
Stringent rules and regulations
During the forecast period, market growth is anticipated to be constrained by the implementation of strict regulations in the healthcare sector to guarantee the highest standards of packaging and labeling services. To ensure compliance with standards and regulations set by the pharmaceutical industry, testing and integrity-related procedures are applied to all kinds of medical packaging. Medical packaging options and equipment must withstand harsh disinfectants and various sterilization processes. Therefore, the medical foam industry faces significant difficulties and a slowdown as a result of the strict rules and regulations.
The COVID-19 pandemic had a negative impact on the world economy, which is causing GDP in those economies to decline. This will change consumer spending patterns around the world. Because of the rise in COVID-19 infections, there are more patients being admitted to hospitals. People who have COVID-19 infections that are severe need breathing apparatus to manage their infections. This is a significant contributing factor to the increased use of medical foam in the support of anesthesia and breathing apparatus.
The flexible foam segment is expected to be the largest during the forecast period
The flexible foam segment dominated the medical foam market and is predicted to witness largest share during the forecast period. The expansion of this market can be attributed to the growing use of flexible foam in applications such as bedding and cushioning, wound dressing, and medical packaging. Additionally, flexible medical foam is well suited for use in a variety of applications due to its distinctive properties.
The polyolefin segment is expected to have the highest CAGR during the forecast period
Due to its expanding use in medical packaging and components in the healthcare sector, polyolefin is anticipated to experience the fastest growth over the forecast period. As a result of their excellent insulation and vibration-dampening qualities, they are frequently used for packaging delicate instruments and devices. Additionally, because it is simple to make and has a high load-bearing capacity, producers can use less and thinner foam, lowering the cost of packaging. Such aspects are boosting the segment's expansion.
Region with largest share:
North America dominated the market and is expected to hold largest share over the forecast period due to the rising per capita health expenditure in the U.S. The demand for medical foam in the area is probably going to increase as a result. One of the key trends affecting the market in North America is the rise in per capita healthcare spending in the United States, which takes the form of health insurance. Over the ensuing years, this is anticipated to increase demand for both generic medications and medical equipment, driving the regional market.
The Asia-Pacific medical foam market size is projected to grow at the highest CAGR during the forecast period. The main factors driving the expansion of the medical foam market in this region are the expansion of hospitals, the development of the medical tourism industry, and the rise in the number of elderly people. Moreover, number of variables, including wound size, location, duration, and depth, are taken into account by major players in the Asia-Pacific region in order to manufacture medical foam that is appropriate for treating wounds.
Some of the key players profiled in the Medical Foam Market include 3M, Armacell International Holding GmbH, Avery Dennison Corp., BASF SE, Foamtec Medical, Freudenberg Group, FXI Holdings, Inc., General Plastics Manufacturing Company, Inc., Huntsman International LLC., INOAC Corporation, Molnlycke Health Care, Recticel NV, Rogers Corporation, Sekisui Chemical Co., Ltd., The Dow Chemical Company, Trelleborg AB, UFP Technologies, Inc. and Zotefoams plc.
In January 2022, UFP Technologies announced the acquisition of medical device contract manufacturer DAS Medical. The amount was not disclosed.
In February 2021, Nexus Spine introduced spinal implants. Nexus Spine debuted its PressOn patient-specific fixation system for human spine stabilization, as well as its Tranquil flexible titanium device for interbody fusion.
In June 2020, Xenco Medical Announced the Nationwide Launch of CancelleX Bio-inspired Spinal Implants, the First Injection-Molded Titanium Foam Spinal Implants Pre-Attached to Disposable Instruments.
Form Types Covered:
Materials Covered:
Applications Covered:
Regions Covered:
All the customers of this report will be entitled to receive one of the following free customization options: